Overview

Local Registration Trial in China Humalog Mix 50

Status:
Completed

Trial end date:
2006-04-01

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to compare the 2-hour PPBG excursion following a standard test meal in insulin-requiring diabetic patients treated twice daily with human insulin mix 50/50, versus the 2-hour PPBG excursion in patients treated twice daily with insulin lispro mix 50/50.

Phase:

Phase 3

Details

Lead Sponsor:

Eli Lilly and Company

Treatments:

Insulin
Insulin Lispro
Insulin, Globin Zinc
Isophane insulin, insulin lispro drug combination 50:50